Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Preclinical research summary Preclinical investigations have evaluated AOD9604 in obese murine models and in 3-adrenergic receptor knockout mice, using lipid metabolism and body composition endpoints to support mechanistic hypotheses regarding adipose biology
Within that metabolic field 5-Amino-1MQ occupies a distinct place: it is not a peptide, but a small research molecule described in research models as an inhibitor of the enzyme NNMT, which makes it of interest within NAD+ focused metabolic research
Daily 1,000 mcg Dosing for First Week The first step is giving 1,000 mcg of Vitamin B12 daily for a week
In a notable phase II clinical trial published in The Lancet (2008), Tesofensine demonstrated dose-dependent weight loss of up to 10.6% over 24 weeks in obese individualssubstantially higher than placebo or many existing weight-loss drugs
